Found: 7
Select item for more details and to access through your institution.
Structure-Activity Relationships Based on the Peptide Leukotriene Receptor Antagonist, ICI 198,615 Enhancement of Potency.
- Published in:
- Annals of the New York Academy of Sciences, 1988, v. 524, n. 1, p. 458, doi. 10.1111/j.1749-6632.1988.tb38588.x
- By:
- Publication type:
- Article
Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 26, n. 7, p. 1063, doi. 10.1111/j.1365-2036.2007.03452.x
- By:
- Publication type:
- Article
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 3, p. 421, doi. 10.1111/j.1365-2036.2006.02764.x
- By:
- Publication type:
- Article
Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 17, n. 4, p. 553, doi. 10.1046/j.1365-2036.2003.01459.x
- By:
- Publication type:
- Article
Efficacy of enzyme immunoassay for the detection of Helicobacter pylori antigens in frozen stool specimens: local validation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2002, v. 16, n. 10, p. 1739, doi. 10.1046/j.1365-2036.2002.01338.x
- By:
- Publication type:
- Article
Rabeprazole-based 3-day and 7-day triple therapy vs. omeprazole-based 7-day triple therapy for the treatment of Helicobacter pylori infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2001, v. 15, n. 12, p. 1959, doi. 10.1046/j.1365-2036.2001.01118.x
- By:
- Publication type:
- Article
Evaluation of five commercial serological tests for the detection of Helicobacter pylori infection in Chinese.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2001, v. 15, n. 5, p. 703, doi. 10.1046/j.1365-2036.2001.00961.x
- By:
- Publication type:
- Article